Ventricular Preexcitation in Hypertrophic Cardiomyopathy: Dove or a Hawk?
2023; Lippincott Williams & Wilkins; Volume: 16; Issue: 11 Linguagem: Inglês
10.1161/circep.123.012543
ISSN1941-3149
Autores Tópico(s)Cardiac Structural Anomalies and Repair
ResumoHomeCirculation: Arrhythmia and ElectrophysiologyVol. 16, No. 11Ventricular Preexcitation in Hypertrophic Cardiomyopathy: Dove or a Hawk? No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextVentricular Preexcitation in Hypertrophic Cardiomyopathy: Dove or a Hawk? Henry Chubb and Anne M. Dubin Henry ChubbHenry Chubb https://orcid.org/0000-0002-2859-3536 Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, CA. Lucile Packard Children's Hospital, Stanford, Palo Alto, CA. and Anne M. DubinAnne M. Dubin Correspondence to: Anne M. Dubin, MD, Heart Center Research Core, Stanford University, 750 Welch Rd, Palo Alto, CA 94304-5701. Email E-mail Address: [email protected] https://orcid.org/0000-0002-3786-1408 Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, CA. Lucile Packard Children's Hospital, Stanford, Palo Alto, CA. Originally published3 Nov 2023https://doi.org/10.1161/CIRCEP.123.012543Circulation: Arrhythmia and Electrophysiology. 2023;16This article is a commentary on the followingHypertrophic Cardiomyopathy and Ventricular Preexcitation in the Young: Cause and Accessory Pathway CharacteristicsFootnotesFor Disclosures, see page 607.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Anne M. Dubin, MD, Heart Center Research Core, Stanford University, 750 Welch Rd, Palo Alto, CA 94304-5701. Email amdubin@stanford.eduREFERENCES1. Przybylski R, Vijayashankar SS, O'Leary E, Hylind RJ, Noon J, Dionne A, DeWitt ES, Bezzerides VJ, Abrams DJ. Hypertrophic cardiomyopathy and ventricular preexcitation in the young: etiology and accessory pathway characteristics.Circ Arrhythm Electrophysiol. 2023; 16:e012191. doi: 10.1161/CIRCEP.123.012191LinkGoogle Scholar2. Pieroni M, Ciabatti M, Saletti E, Tavanti V, Santangeli P, Martinese L, Liistro F, Olivotto I, Bolognese L. Beyond Sarcomeric hypertrophic cardiomyopathy: How to diagnose and manage phenocopies.Curr Cardiol Rep. 2022; 24:1567–1585. doi: 10.1007/s11886-022-01778-2CrossrefMedlineGoogle Scholar3. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.Circulation. 2003; 107:2850–2856. doi: 10.1161/01.CIR.0000075270.13497.2BLinkGoogle Scholar4. Thevenon J, Laurent G, Ader F, Laforet P, Klug D, Duva Pentiah A, Gouya L, Maurage CA, Kacet S, Eicher JC, et al. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.Europace. 2017; 19:651–659. doi: 10.1093/europace/euw067CrossrefMedlineGoogle Scholar5. Darden D, Hsu JC, Tzou WS, von Alvensleben JC, Brooks M, Hoffmayer KS, Brambatti M, Sauer WH, Feld GK, Adler E. Fasciculoventricular and atrioventricular accessory pathways in patients with Danon disease and preexcitation: a multicenter experience.Heart Rhythm. 2021; 18:1194–1202. doi: 10.1016/j.hrthm.2021.03.024CrossrefMedlineGoogle Scholar6. Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziolkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, et al. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.Eur J Prev Cardiol. 2022; 29:645–653. doi: 10.1093/eurjpc/zwab046CrossrefMedlineGoogle Scholar7. Carlson AM, Turek JW, Law IH, Von Bergen NH. Pseudo-preexcitation is prevalent among patients with repaired complex congenital heart disease.Pediatr Cardiol. 2015; 36:8–13. doi: 10.1007/s00246-014-0955-xCrossrefMedlineGoogle Scholar8. Tikenogullari OZ, Peirlinck M, Chubb H, Dubin AM, Kuhl E, Marsden AL. Effects of cardiac growth on electrical dyssynchrony in the single ventricle patient.Comput Methods Biomech Biomed Engin. 2023; 1:1–17. doi: 10.1080/10255842.2023.2222203CrossrefGoogle Scholar9. Macias Y, Tretter JT, Anderson RH, Sanchez-Quintana D, Soares Correa F, Farre J, Back Sternick E. Miniseries 1-part IV: how frequent are fasciculo-ventricular connections in the normal heart?Europace. 2022; 24:464–472. doi: 10.1093/europace/euab286CrossrefMedlineGoogle Scholar10. Etheridge SP, Escudero CA, Blaufox AD, Law IH, Dechert-Crooks BE, Stephenson EA, Dubin AM, Ceresnak SR, Motonaga KS, Skinner JR, et al. Life-threatening event risk in children with Wolff-Parkinson-white syndrome: a multicenter international study.JACC Clin Electrophysiol. 2018; 4:433–444. doi: 10.1016/j.jacep.2017.10.009CrossrefMedlineGoogle Scholar11. Beach C, Follansbee CW, Beerman L, Mazzocco S, Wang L, Arora G. Adenosine-sensitive Wolff-Parkinson-White: longer time across the atrioventricular groove.Pacing Clin Electrophysiol. 2018; 41:35–41. doi: 10.1111/pace.13257CrossrefMedlineGoogle Scholar12. Ghosh S, Avari JN, Rhee EK, Woodard PK, Rudy Y. Hypertrophic cardiomyopathy with preexcitation: insights from noninvasive electrocardiographic imaging (ECGI) and catheter mapping.J Cardiovasc Electrophysiol. 2008; 19:1215–1217. doi: 10.1111/j.1540-8167.2008.01203.xCrossrefMedlineGoogle Scholar13. van Capelle CI, Poelman E, Frohn-Mulder IM, Koopman LP, van den Hout JMP, Regal L, Cools B, Helbing WA, van der Ploeg AT. Cardiac outcome in classic infantile pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase.Int J Cardiol. 2018; 269:104–110. doi: 10.1016/j.ijcard.2018.07.091CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesHypertrophic Cardiomyopathy and Ventricular Preexcitation in the Young: Cause and Accessory Pathway CharacteristicsRobert Przybylski, et al. Circulation: Arrhythmia and Electrophysiology. 2023;16 November 2023Vol 16, Issue 11 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCEP.123.012543PMID: 37920987 Originally publishedNovember 3, 2023 KeywordsEditorialsaccessory atrioventricular bundlecardiomyopathy, hypertrophiccatheter ablationdeath, sudden, cardiacWolff-Parkinson-White SyndromePDF download Advertisement SubjectsCardiomyopathyElectrophysiologyGeneticsHypertrophyPediatrics
Referência(s)